Investment Thesis
Aimei Health is a blank check company with critical financial distress, including negative stockholders' equity of -$3.4M, virtually no liquid cash ($3K), and severe liquidity crisis with current ratio of 0.01x. The company is burning cash with negative operating cash flow of -$521.9K despite reporting positive net income, signaling accounting quality concerns and unsustainable operations.
Strengths
- Reported net income of $961.7K in latest period
- Total assets of $45.5M provide some asset base
- Relatively low total liabilities of $3.5M compared to assets
Risks
- Negative stockholders' equity of -$3.4M indicates insolvency
- Critical liquidity crisis with only $3K cash and 0.01x current ratio - immediate solvency risk
- Negative operating cash flow of -$521.9K contradicts positive net income - potential accounting manipulation or non-cash gains
- No revenue reported - business model not operational
- Negative operating income of -$585.2K
- Blank check company status indicates pre-merger/acquisition stage with unproven business model
- Zero insider buying activity signals lack of management confidence
Key Metrics to Watch
- Cash position and runway to funding/merger completion
- Operating cash flow sustainability and reconciliation with net income
- Stockholders' equity recovery path and capitalization timeline
- Revenue generation post-acquisition or business combination
- Current ratio improvement and working capital management
Financial Metrics
Revenue
N/A
Net Income
961.7K
EPS (Diluted)
$0.08
Free Cash Flow
-521.9K
Total Assets
45.5M
Cash
3.0K
Profitability Ratios
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
ROE
N/A
ROA
2.1%
FCF Margin
N/A
Balance Sheet & Liquidity
Current Ratio
0.01x
Quick Ratio
0.01x
Debt/Equity
N/A
Debt/Assets
7.6%
Interest Coverage
N/A
Long-term Debt
N/A
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-03-19T16:36:10.837454 |
Data as of: 2025-09-30 |
Powered by Claude AI